Close
Almac
Achema middle east

Tessol launches cold solutions for vaccine delivery

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.
- Advertisement -

Tessol has launched a solution for vaccine delivery across India to aid the massive COVID-19 vaccination drive undergoing in the country. The company has launched the vaccine-delivery solution keeping in mind the massive ongoing drive in India to inoculate each and every Indian. The startup has already attained tremendous success in other industries where maintaining a cold chain during logistics is critical, a statement from the company said.

Tessol has already partnered with Reliance regarding its vaccine programme for the company.

In India, with the focus on vaccine distribution, there has been a massive surge in demand for temperature-controlled distribution. The demand for such solutions providers has further spiked by the increased consumer awareness and the need to comply with essential quality standards. TESSOL is currently targetting to tap this market as India gets into mass vaccination overdrive.

Speaking about the launch, Rajat Gupta, CEO, TESSOL, said, “The entire world is going through a challenging phase due to the ongoing pandemic. The only way to halt the ongoing growth in infection is by vaccinating a maximum of Indians. We at TESSOL feel privileged to be able to launch vaccine-delivery solutions for pharma companies, logistics companies and organisations. We hope to contribute to this massive cause of vaccination for Indians by means of our technological abilities and past successes.”

TESSOL solutions allow pharma companies/logistics providers to offer end-to-end transportation of vaccine packages from the source to end customers without breaking the cold chain up in a highly temperature-controlled environment.

Latest stories

Related stories

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Samsung Biologics to Buy US Drug Plant from GSK for $280M

On December 22, 2025, the news has been confirmed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »